Company: CERO
Filing Date: 2025-11-17
Form Type: NT 10-Q
Source: 0001213900-25-111295
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: NT 10-Q
Chunk 3
---
 expectations,
hopes, beliefs, intentions or strategies regarding the future, including statements about the timing of the filing of the Quarterly Report
and statements about the preliminary financial results for the quarter ended September 30, 2025. Forward-looking statements are typically
identified by words such as “plan,” “believe,” “expect,” “anticipate,” “intend,”
“outlook,” “estimate,” “forecast,” “project,” “continue,” “could,”
“may,” “might,” “possible,” “potential,” “predict,” “should,”
“would” and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the
current expectations of the management of the Company and are inherently subject to uncertainties and changes in circumstances and their
potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that
have been anticipated. Forward-looking statements reflect material expectations and assumptions, including, without limitation, expectations,
and assumptions relating to the Company’s auditors being able to complete their review of the quarterly financial statements in
a timely manner. Such expectations and assumptions are inherently subject to uncertainties and contingencies regarding future events and,
as such, are subject to change. Forward-looking statements involve a number of risks, uncertainties or other factors that may cause actual
results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and
uncertainties include, but are not limited to, those discussed and identified in public filings made by the Company with the Securities
and Exchange Commission (the “SEC”) and the Company’s auditors being unable to complete their review of the quarterly
financial statements in a timely manner and the Company consequently not filing the Quarterly Report within the time period prescribed
in Rule 12b-25 promulgated under the Securities Exchange Act of 1934.

Any financial results discussed in this document
are preliminary and represent the most current information available to the Company’s management as of November 14, 2025, as financial
closing procedures for the quarter year ended September 30, 2025 are not yet complete. These estimates are not a comprehensive statement
of the Company’s financial results for the quarter ended September 30, 2025, and actual results may differ materially from these
estimates as a result of the completion of quarter-end accounting procedures and adjustments, including the execution of the Company